Glycobiology-driven therapeutic targeting of glycan-binding proteins: mechanisms, diseases, and clinical translation.
Saved in:
| Title: | Glycobiology-driven therapeutic targeting of glycan-binding proteins: mechanisms, diseases, and clinical translation. |
|---|---|
| Authors: | Popatia AM; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.; University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada.; Ottawa Institute of Systems Biology, Ottawa, ON, Canada., Sharanek A; University of Bordeaux, INSERM, U1312, Bordeaux Institute of Oncology, Bordeaux, France. ahmad.charanek@u-bordeaux.fr., Jahani-Asl A; Department of Cellular and Molecular Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada. arezu.jahani@uottawa.ca.; University of Ottawa Brain and Mind Research Institute, Ottawa, ON, Canada. arezu.jahani@uottawa.ca.; Ottawa Institute of Systems Biology, Ottawa, ON, Canada. arezu.jahani@uottawa.ca.; Regenerative Medicine Program and Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada. arezu.jahani@uottawa.ca. |
| Source: | Signal transduction and targeted therapy [Signal Transduct Target Ther] 2026 Jun 05; Vol. 11 (1). Date of Electronic Publication: 2026 Jun 05. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101676423 Publication Model: Electronic Cited Medium: Internet ISSN: 2059-3635 (Electronic) Linking ISSN: 20593635 NLM ISO Abbreviation: Signal Transduct Target Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2059-3635 |
|---|---|
| DOI: | 10.1038/s41392-026-02768-4 |
